Catalyst Wire Dossier Catalyst Wire Dossier

Ondansetron inhalation powder

ondansetron · Luxena Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ondansetron inhalation powder, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase I PK and Safety Study of Ondansetron Inhalation Powder [Phase 1]

See pricing